REKTOROVÁ, Irena, Jiri MEKYSKA, Eva KORIŤÁKOVÁ, Milena KOŠŤÁLOVÁ, Ilona ELIÁŠOVÁ, Martina MRAČKOVÁ, Dagmar BERÁNKOVÁ, Tereza NEČASOVÁ, Zdenek SMEKAL and Radek MAREČEK. Speech prosody impairment predicts cognitive decline in Parkinson's disease. Online. PARKINSONISM & RELATED DISORDERS. OXFORD: ELSEVIER SCI LTD, 2016, vol. 29, August, p. 90-95. ISSN 1353-8020. Available from: https://dx.doi.org/10.1016/j.parkreldis.2016.05.018. [citováno 2024-04-23]
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Speech prosody impairment predicts cognitive decline in Parkinson's disease
Authors REKTOROVÁ, Irena (203 Czech Republic, guarantor, belonging to the institution), Jiri MEKYSKA (203 Czech Republic), Eva KORIŤÁKOVÁ (203 Czech Republic, belonging to the institution), Milena KOŠŤÁLOVÁ (203 Czech Republic, belonging to the institution), Ilona ELIÁŠOVÁ (203 Czech Republic, belonging to the institution), Martina MRAČKOVÁ (203 Czech Republic, belonging to the institution), Dagmar BERÁNKOVÁ (203 Czech Republic, belonging to the institution), Tereza NEČASOVÁ (203 Czech Republic, belonging to the institution), Zdenek SMEKAL (203 Czech Republic) and Radek MAREČEK (203 Czech Republic, belonging to the institution)
Edition PARKINSONISM & RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2016, 1353-8020.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.484
RIV identification code RIV/00216224:14740/16:00088928
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1016/j.parkreldis.2016.05.018
UT WoS 000381955700016
Keywords in English Parkinson's disease; Speech prosody; Acoustic analysis; Cognitive; Dementia
Tags EL OK, podil, rivok
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 16/12/2016 12:52.
Abstract
Background: Impairment of speech prosody is characteristic for Parkinson's disease (PD) and does not respond well to dopaminergic treatment. Objectives: We assessed whether baseline acoustic parameters, alone or in combination with other predominantly non-dopaminergic symptoms may predict global cognitive decline as measured by the Addenbrooke's cognitive examination (ACE-R) and/or worsening of cognitive status as assessed by a detailed neuropsychological examination. Methods: Forty-four consecutive non-depressed PD patients underwent clinical and cognitive testing, and acoustic voice analysis at baseline and at the two-year follow-up. Influence of speech and other clinical parameters on worsening of the ACE-R and of the cognitive status was analyzed using linear and logistic regression. Results: The cognitive status (classified as normal cognition, mild cognitive impairment and dementia) deteriorated in 25% of patients during the follow-up. The multivariate linear regression model consisted of the variation in range of the fundamental voice frequency (F0VR) and the REM Sleep Behavioral Disorder Screening Questionnaire (RBDSQ). These parameters explained 37.2% of the variability of the change in ACE-R. The most significant predictors in the univariate logistic regression were the speech index of rhythmicity (SPIR; p = 0.012), disease duration (p = 0.019), and the RBDSQ (p = 0.032). The multivariate regression analysis revealed that SPIR alone led to 73.2% accuracy in predicting a change in cognitive status. Combining SPIR with RBDSQ improved the prediction accuracy of SPIR alone by 73%. Conclusions: Impairment of speech prosody together with symptoms of RBD predicted rapid cognitive decline and worsening of PD cognitive status during a two-year period. (C) 2016 Elsevier Ltd. All rights reserved.
Links
LQ1601, research and development projectName: CEITEC 2020 (Acronym: CEITEC2020)
Investor: Ministry of Education, Youth and Sports of the CR
NT13499, research and development projectName: Řeč, její poruchy a kognitivní funkce u Parkinsonovy nemoci
NV16-30805A, research and development projectName: Efekt neinvazivní stimulace mozku na hypokinetickou dysartrii, mikrografii a mozkovou plasticitu u pacientů s Parkinsonovou nemocí
PrintDisplayed: 23/4/2024 20:52